Suppr超能文献

肥胖与肾脏疾病。

Obesity and kidney disease.

作者信息

Cignarelli Mauro, Lamacchia Olga

机构信息

Unit of Endocrinology and Metabolic Diseases, Department of Medical Sciences, University of Foggia, Via Luigi Pinto 1, 71100 Foggia, Italy.

出版信息

Nutr Metab Cardiovasc Dis. 2007 Dec;17(10):757-62. doi: 10.1016/j.numecd.2007.03.003. Epub 2007 Jul 2.

Abstract

The prevalence of obesity worldwide has increased dramatically. Besides, an approximately two-fold higher rate of increase in mean BMI among the incident ESRD has been reported in the US population from 1995-2002. Chronic kidney disease (CKD) prevalence increases from 2.9% among adults with an ideal BMI to 4.5% among obese adults. The development of CKD is usually the culminating result of the interaction of multiple risk factors. Obesity represents one example of a multitoxicity state and given the background of genetic susceptibility and/or reduced nephron number, overweight may initiate renal remodeling and/or accelerate kidney failure. Obesity may be the number one preventable risk factor for CKD. Weight loss has indeed been shown to improve glomerular hemodynamics and reduce urine albumin excretion. Thus, obese patients with CKD should be counseled on the benefits of weight loss.

摘要

全球肥胖症的患病率急剧上升。此外,据报道,1995年至2002年美国人群中,新发终末期肾病患者的平均体重指数增长率高出约两倍。慢性肾脏病(CKD)的患病率在理想体重指数的成年人中为2.9%,在肥胖成年人中则为4.5%。CKD的发生通常是多种危险因素相互作用的最终结果。肥胖是一种多毒性状态的例子,在遗传易感性和/或肾单位数量减少的背景下,超重可能引发肾脏重塑和/或加速肾衰竭。肥胖可能是CKD头号可预防的危险因素。事实上,体重减轻已被证明可改善肾小球血流动力学并减少尿白蛋白排泄。因此,应向患有CKD的肥胖患者宣传体重减轻的益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验